Pharmacy

Your Article Summary

See Latest Articles

Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting
Current Medical Research and Opinion, 06/25/09

Ritzwoller DF et al. - The presence of pDPN in patients with diabetes was associated with significantly greater comorbidity, greater healthcare service utilization, and higher costs. While this study is limited to the direct medical care costs borne by the health plan, given the association of comorbidities and cost for patients with pDPN, further investigation is needed to determine if management approaches that are effective across chronic illnesses may prove to be beneficial for high cost diabetes patients.

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Vitiligo therapy
Expert Opinion in Pharmacotherapy, 12/01/09

A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients
Bone , 12/01/09

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09

 See all of Other Drugs

Today in Pharmacoeconomics...keeping you current

Receive free subspecialty "5-minute updates" via email

Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
PharmacoEconomics, 11/30/09

Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
PharmacoEconomics, 11/24/09

Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09

 See all of Pharmacoeconomics